Category: Prescription Drugs
Prescription Drugs market research reports by GlobalData
-
Hyperlipidemia: Competitive Landscape
Hyperlipidemia: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hyperlipidemia therapeutics. GlobalData epidemiologists estimate 128,720,003 total prevalent cases of high low-density lipoprotein C (LDL-C) with high triglyc ... Read More
-
Acute-on-Chronic Liver Failure: Competitive Landscape
Acute-on-Chronic Liver Failure: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Acute-on-Chronic Liver Failure therapeutics. GlobalData epidemiologists estimated that there are 71,713 diagnosed incident cases of acute-on-c ... Read More
-
Rett Syndrome: Competitive Landscape
Rett Syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Rett Syndrome therapeutics. In the 16 countries covered in GlobalData’s epidemiology forecast for Rett syndrome (RS), there are projected to be 97,327 diagnose ... Read More
-
Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition
Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition Summary This expert trend report is a comprehensive look at the pharmaceutical finished dose contract manufacturing landscape in 2024, including analysis of dose CMO M&A activity, market s ... Read More
-
Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes
Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes Summary This report analyzes the disruptive themes that have driven M&A activity in Q3 2024 in the pharma Sector. The global pharma sector in Q3 2024 witnessed deals worth $35 billion, a decline of 3% compared to Q3 2023. In terms of deal ... Read More
-
Neurofibromatoses: Competitive Landscape
Neurofibromatoses: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Nurofibromatoses therapeutics. In 2024, more than 986,000 diagnosed prevalent cases of Nurofibromatoses are anticipated in the 16 countries covered in Glob ... Read More
-
Migraine: 68-Market Analysis and Sales Forecast
Migraine: 68-Market Analysis and Sales Forecast Summary GlobalData estimates that the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventative treatments including widely used triptans and ergot alkaloids used in abortive treatment a ... Read More
-
Migraine: Seven-Market Drug Forecast and Market Analysis
Migraine: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Migraine market through 2033. GlobalData estimates that the value of the migraine market in the 7MM in 2023 wa ... Read More
-
Chronic Urticaria: Competitive Landscape
Chronic Urticaria: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in chronic urticaria therapeutics. In 2024, more than 60 million diagnosed prevalent cases of CU are anticipated in the 16 countries covered in GlobalData’s e ... Read More
-
Clinical Trials: Psychedelic Therapeutics
Clinical Trials: Psychedelic Therapeutics Summary This report provides a review of global psychedelic therapeutic clinical trials derived from the GlobalData’s Clinical Trials Database. The aim of this report is to identify key analyses and segmentations of these trials. As the number of psychedelic ... Read More
-
Substance (Drug) Abuse - Global Clinical Trials Review, 2024
Substance (Drug) Abuse - Global Clinical Trials Review, 2024 Substance (Drug) Abuse - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Substance (Drug) Abuse - Global Clinical Trials Review, 2024"" provides an overview of Substance (Drug) Abuse Clinical trials scenari ... Read More
-
Osteoporosis: Seven-Market Drug Forecast and Market Analysis
Osteoporosis: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Osteoporosis market through 2033. Osteoporosis is defined as a systemic skeletal disease characterized by ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Attention Deficit Hyperactivity Disorder (ADHD) market through 2032. The ... Read More
-
New Prescription - Generative AI meets Healthcare (Vol. 2)
New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More
-
Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs
Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs Summary This comprehensive conversation analysis report delves into the most popular weight loss drugs on Reddit in the last six months (October 1st, 2023, to March 31st, 2024), offering a nuanced understanding of their prominence and po ... Read More
-
Psychedelics Therapeutics Development and Trends, 2024
Psychedelics Therapeutics Development and Trends, 2024 Summary This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. ... Read More
-
Pharma M&A Deals 2023 - Top Themes - Thematic Research
Pharma M&A Deals 2023 - Top Themes - Thematic Research Summary This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Pharma Sector The global pharma sector in 2023 witnessed deals worth $233 billion, a growth of 81% compared to 2022. In terms of deal volume also, th ... Read More
-
Dyspepsia Drugs Market - Indication (Functional, Organic), Drug Type (Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics), Medication (Branded, Generic), Mode (OTC, Prescription), Distribution Channel, Global Forecast (2024-2032)
Dyspepsia Drugs Market - Indication (Functional, Organic), Drug Type (Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics), Medication (Branded, Generic), Mode (OTC, Prescription), Distribution Channel, Global Forecast (2024-2032) Dyspepsia Drugs Market is expected to witness 4.5 ... Read More
-
France Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
France Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “France Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France Reversible Contraceptive Procedures. The databook report ... Read More
-
United States (US) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
United States (US) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “United States Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United States Reversible Contraceptive Proced ... Read More
-
United Kingdom (UK) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
United Kingdom (UK) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “United Kingdom Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Reversible Contraceptive Pro ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PTSD therapeutics. Scope GlobalData’s PTSD: Competitive Landscape combines d ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and ... Read More
-
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ASD therapeutics. There will be over 9.8 million diagnosed prevalent cases of ASD i ... Read More
-
Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029
Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides ... Read More
Research Assistance
